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David L. Blazes1*, Mark S. Riddle2 and Edward T. Ryan3Dengue in Tokyo and Key West. Leishmaniasis in
Madrid and Texas. Chikungunya in Ravenna and Puerto
Rico. SARS in Toronto. Ebola in Dallas. And measles
everywhere. Population growth, globalization, climate
change and urbanization together are reshaping the con-
text upon which we must consider the global spread of
emerging and historically tropical infectious diseases and
their interface with non-communicable diseases of tran-
sitioning societies.
We live on a crowded and interconnected planet,
with a projected global human population of at least
9 billion by 2050 [1]. Public health advances such as
safe water, adequate sanitation, antibiotics, vaccines
and balanced nutrition programs have extended over-
all life expectancy, even in remote, under-developed
settings. The resulting unprecedented population
surge has contributed to numerous challenges that
will increasingly serve as counter-balances to these
public health advances and will synergize with other
inter-related factors such globalization, climate change
and urbanization to contribute to the spread of dan-
gerous infectious diseases.
International travel and immigration increase each
year, with more than 1 billion humans crossing inter-
national borders in 2013 alone [2]. Many cross to em-
brace economic opportunities or to escape war or
disaster. Many also travel to visit family or friends, or for
business, education or leisure purposes. Exotic, remote
and dangerous locations—often lacking public health in-
frastructure—are increasingly common destinations for
travelers as well as sources of immigrants to the devel-
oped world. This “smaller world” effect brings with it
much good in terms of societal connectedness and eco-
nomic stimulation, but also individual risk to the traveler
and the opportunity for spread of disease upon return.
Our current age of globalization also involves the in-
creasingly rapid and direct transportation of food and* Correspondence: david.l.blazes.mil@mail.mil
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transmission, whether it be cyclosporiasis associated
with Latin America raspberries, [3] enterohemorrhagic
E. coli infection associated with Middle Eastern fenu-
greek sprouts, [4] monkeypox from pet Gambian rats
and prairie dogs, [5] or introduction into the US of Ae-
des albopictus (the Asian Tiger mosquito and potential
vector of dengue and chikungunya) via imported used-
tires from Asia [6].
Evolving global climate change and severe weather
events can also be expected to have significant impacts
on the distribution, spread and burden of many tropical
and global infections; unfortunately, we just do not yet
have the ability to accurately predict what these impacts
will be. Two obvious areas that warrant special surveil-
lance are vector-borne and water-borne diseases. For in-
stance, regional burdens of malaria, dengue and
chikungunya may all increase with the effect of increas-
ing temperature on their mosquito vectors, and cholera
and leptospirosis can increase in the setting of flooding
associated with severe weather events [7]. The effect of
severe weather on fragile health infrastructures will fur-
ther undermine detection and control efforts, facilitating
spread of pathogens. As the climate changes, unpredict-
able outcomes are also very likely, as humans alter their
behavior in the setting of changing ecosystems, poten-
tially increasing the likelihood of introducing new zoo-
notic infections into human populations.
The urbanization of the human population is impact-
ing the risk of transmission of many infectious agents.
Currently, more than 80 % of humans live in developing
countries, and more than half of these people now live
in urban settings, many in informal settlement or slum
conditions (esa.un.org/unpd/wup/FinalReport/WUP2014.
pdf Accessed 12 June 2015). This dense concentration of
people lacking appropriate infrastructure support facili-
tates the transmission of contagious diseases while provid-
ing a ready source of susceptible individuals, whether it be
influenza, typhoid fever or Ebola.ticle distributed under the terms of the Creative Commons Attribution License
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of infant and child mortality, though there is still a long
way to go. The anticipated health, demographic and eco-
nomic dividends of such an achievement has observed
and anticipated consequences. However, with resultant
increased life expectancy, the rise in cardiovascular and
other chronic diseases represents a double burden.
Scarce dollars will need to be effectively managed to ad-
dress all population health issues.
We must face the reality that emerging infections are
the norm and infections previously confined to one geo-
graphic location are now often globally relevant. Non-
communicable diseases are extremely important, but we
need not lose sight of the fact that infectious diseases
still account for significant mortality and morbidity. Pro-
jections suggest that over the next few decades, infec-
tious diseases will still account for one of five deaths
globally [8]. Vaccines have been a major advancement
with millions of deaths prevented each year by vaccin-
ation. However, challenges lay ahead in expanding the
availability of existing vaccines to those in most need,
development of new vaccines for malaria, HIV, dengue
and enteric pathogens, and a dwindling capacity to add
more vaccines to programs of immunization. Eradication
(such as with current polio efforts) may alleviate the
latter issue, though better delivery and program man-
agement science is needed to achieve more timely and
cost-effective success. There are, however, many infec-
tious disease challenges for which vaccines are not
likely to be solutions, such as less common neglected
tropical infections, the misuse of antimicrobials agents,
the emergence and spread of multi-drug resistant or-
ganisms, and the rate of nosocomial infections. These
all suggest that, even in resource-rich environments,
we still need to make significant investments in com-
bating infectious pathogens through advancements in
policy.
Today, everyone lives internationally— even if they
themselves have never left the community where they
were born. No one knows what the future will hold, but
recent and daily events strongly suggest that we will
need to be adaptable to meet the emerging and evolving
infectious challenges that lie ahead.
The journal of Tropical Diseases, Travel Medicine and
Vaccines (TDTMV) was created with the hope of provid-
ing a forum where important discovery, observation and
insights may find a global audience. As an open access
journal, TDTMV articles will be freely available, and
through an article-processing charge waiver program for
researchers from low and low-middle income countries
(as defined by the World Bank in September 2014) [9],
we hope that this journal provides a forum for all, inde-
pendent of ones means. The journal’s scope covers a
broad range of topics, and in particular, will provide aforum for underserved topics such as chronic diseases in
the developing world and migration medicine. Further-
more, TDTMV will endeavor to provide a much-needed
forum for targeted updates in clinical tropical and travel
medicine to serve as an easily-accessible source for the
busy practitioner and trainee.
Finally, the launch and future success of this journal is
dependent upon the esteemed Editorial Board, the peer
reviewers and you. Thus, we welcome you to submit
your research, observations, experience and perspectives
to Tropical Diseases, Travel Medicine and Vaccines, not
only to help the journal become a top journal in its field,
but also improve the lives of many through shared
knowledge. Our many thanks in advance.
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